So hemo has finished down 30% this year despite all the cheerleaders telling how much it would rise into IND
Sadly there is one reason for our SP and that is Vlad ..the market has no faith in him due to the history of this share and lack of following through with products. All we can hope for is that CAR-T works although with only 1 patient a month for 20 months it could still be another year before we find out.
I see COVID shares such as novacyt are having a great day....sadly not hemo ....a CBR update is needed now and this could fly given the China situation!
Indeed Tommy you are absolutely correct...magenta is now sub $25m..Mcap..looks like their shareholders have suffered as much as we have, and we havent even failed yet !
RE: No one can explain this rubbish ...15 Dec 2022 17:27
Vlad needs to deliver a successful partnership for there to be any confidence ..all his past partnerships have not delivered ..huphec ..J&J with Lupus, and globalco all fizzled away ..